INTROVALE
Levonorgestrel and Ethinyl Estradiol tablets · KIT · Xiromed LLC
INTROVALE is a kit containing levonorgestrel and ethinyl estradiol tablets. Manufactured by Xiromed LLC.
Key Facts
- Brand Name
- INTROVALE
- Generic Name
- Levonorgestrel and Ethinyl Estradiol tablets
- NDC Code (Product)
70700-208- Manufacturer
- Xiromed LLC
- Dosage Form
- KIT
- Marketing Status
- Application #
- ANDA200490
- Marketing Start
- 01/29/2025
Recall History
Sandoz Incorporated
Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card
Frequently Asked Questions
What is INTROVALE used for?
INTROVALE contains Levonorgestrel and Ethinyl Estradiol tablets. It is a kit taken as directed. Consult your doctor for specific uses.
Is INTROVALE a controlled substance?
INTROVALE is not classified as a controlled substance by the DEA.
What is the generic name for INTROVALE?
The generic name for INTROVALE is Levonorgestrel and Ethinyl Estradiol tablets. There are no other listed brand versions of Levonorgestrel and Ethinyl Estradiol tablets.
What is the NDC code for INTROVALE ?
The NDC (National Drug Code) for INTROVALE is 70700-208, listed by Xiromed LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)